TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 6 March 15, 2011
(The next issue will be on April 1, 2011)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PRODUCT ANNOUNCEMENT
Haematologic Technologies, Inc. supplies a full range of purified proteins and antibodies for use in thrombosis research. These proteins include:
DISCLAIMER: Commercial product announcements appearing in TRIGGER are provided "as is" for informational purposes only. The editors of TRIGGER have not necessarily evaluated any materials from commercial suppliers described in this newsletter or on its web sites, and we certainly are not endorsing any specific suppliers or products. Furthermore, the editors receive no revenues from any source in the course of publishing TRIGGER.
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1FGVdsJU0ltAxZc9wpEu1M6/
(No authors listed) (2010) [Diagnosis and correction of thrombohemorrhagic complications in cardiosurgical patients in the early postoperative period]. Anesteziol Reanimatol:56-59.
http://www.ncbi.nlm.nih.gov/pubmed/21400731
Agerso H, Kristensen NR, Ostergaard H, Karpf DM, Hermit MB, Pelzer H, . . . Ezban M (2011) Clearance of rFVIIa and NN1731 after intravenous administration to Beagle dogs. Eur J Pharm Sci.
http://www.ncbi.nlm.nih.gov/pubmed/21382491
Brophy DF, Martin EJ, Christian Barrett J, Nolte ME, Kuhn JG, Gerk PM, . . . Hedner U (2011) Monitoring rFVIIa 90 mug kg(-1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21362113
Brown C, Joshi B, Faraday N, Shah A, Yuh D, Rade JJ, Hogue CW (2011) Emergency Cardiac Surgery in Patients with Acute Coronary Syndromes: A Review of the Evidence and Perioperative Implications of Medical and Mechanical Therapeutics. Anesth Analg.
http://www.ncbi.nlm.nih.gov/pubmed/21385977
Christensen MC, Banner C, Lefering R, Vallejo-Torres L, Morris S (2011) Quality of Life After Severe Trauma: Results From the Global Trauma Trial With Recombinant Factor VII. J Trauma.
http://www.ncbi.nlm.nih.gov/pubmed/21378585
Delluc A, Rousseau A, Delluc C, Le Moigne E, Le Gal G, Mottier D, . . . Lacut K (2011) Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21372691
Dimou AT, Syrigos KN, Saif MW (2011) Novel Agents in the Management of Pancreatic Adenocarcinoma: Phase I Studies. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. JOP 12:114-116.
http://www.ncbi.nlm.nih.gov/pubmed/21386633
Eisenreich A, Boltzen U, Malz R, Schultheiss HP, Rauch U (2011) Overexpression of Alternatively Spliced Tissue Factor Induces the Pro-Angiogenic Properties of Murine Cardiomyocytic HL-1 Cells. Circ J.
http://www.ncbi.nlm.nih.gov/pubmed/21389637
Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, . . . Shann KG (2011) 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91:944-982.
http://www.ncbi.nlm.nih.gov/pubmed/21353044
Gando S, Sawamura A, Hayakawa M (2011) Trauma, Shock, and Disseminated Intravascular Coagulation: Lessons from the Classical Literature. Ann Surg.
http://www.ncbi.nlm.nih.gov/pubmed/21368657
Ho KM, Leonard AD (2011) Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study. Anaesth Intensive Care 39:46-54.
http://www.ncbi.nlm.nih.gov/pubmed/21375089
Holmberg H, Kiersgaard MK, Mikkelsen LF, Tranholm M (2011) Impact of blood sampling technique on blood quality and animal welfare in haemophilic mice. Lab Anim.
http://www.ncbi.nlm.nih.gov/pubmed/21382833
Ignjatovic V, Than J, Summerhayes R, Newall F, Horton S, Cochrane A, Monagle P (2011) Hemostatic Response in Paediatric Patients Undergoing Cardiopulmonary Bypass Surgery. Pediatr Cardiol.
http://www.ncbi.nlm.nih.gov/pubmed/21360266
Jiang M, Wang Z, Yu Z, Bai X, Su J, Cao L, . . . Ruan C (2011) A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21372693
Kayem G, Kurinczuk J, Alfirevic Z, Spark P, Brocklehurst P, Knight M (2011) Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG.
http://www.ncbi.nlm.nih.gov/pubmed/21392247
Krysiak R, Zmuda W, Okopien B (2011) The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia. Fundam Clin Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/21392096
Kung CW, Lee YM, Yen MH (2011) In vivo anticoagulant effect of ethyl pyruvate in endotoxemic rats. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21396682
Lockwood CJ, Huang SJ, Krikun G, Caze R, Rahman M, Buchwalder LF, Schatz F (2011) Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia. Semin Thromb Hemost 37:158-164.
http://www.ncbi.nlm.nih.gov/pubmed/21370218
Lwaleed BA, Dusse L, Cooper AJ (2011) Tissue factor dependent pathway and the diagnosis of pre-eclampsia. Semin Thromb Hemost 37:125-130.
http://www.ncbi.nlm.nih.gov/pubmed/21370212
Machlus KR, Cardenas JC, Church FC, Wolberg AS (2011) Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/21355090
Morfini M, Bjerre J (2011) Pharmacokinetics and safety of a 270 mcg kg(-1) dose of room temperature stable recombinant activated factor VII in patients with haemophilia. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21371194
Negrev N, Tashev R, Radev R, Anogeianaki A, Ivanova M (2011) Hormones of hypothalamic-pituitary-thyroid axis are significant regulators of synthesis and secretion of vitamin K-dependent plasma coagulation factors. J Biol Regul Homeost Agents 25:21-26.
http://www.ncbi.nlm.nih.gov/pubmed/21382270
Ott I (2011) Inhibitors of the initiation of coagulation. Br J Clin Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/21392058
Rochier A, Nixon A, Yamashita N, Abe R, Madri JA, Sumpio BE (2011) Laminar shear, but not orbital shear, has a synergistic effect with thrombin stimulation on tissue factor expression in human umbilical vein endothelial cells. J Vasc Surg.
http://www.ncbi.nlm.nih.gov/pubmed/21367569
Sakai T, Inoue S, Takei M, Ogawa G, Hamazaki Y, Ota H, Koboyashi Y (2011) Activated inflammatory cells participate in thrombus size through tissue factor and plasminogen activator inhibitor-1 in acute coronary syndrome: Immunohistochemical analysis. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21388659
Schweintzger S, Schlagenhauf A, Leschnik B, Rinner B, Bernhard H, Novak M, Muntean W (2011) Microparticles in newborn cord blood: Slight elevation after normal delivery. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21376371
Uszynski M, Uszynski W (2011) Coagulation and fibrinolysis in amniotic fluid: physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia. Semin Thromb Hemost 37:165-174.
http://www.ncbi.nlm.nih.gov/pubmed/21370219
van den Born BJ, Lowenberg EC, van der Hoeven NV, de Laat B, Meijers JC, Levi M, van Montfrans GA (2011) Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis. J Hypertens.
http://www.ncbi.nlm.nih.gov/pubmed/21372741
Waters EK, Genga RM, Schwartz MC, Nelson JA, Schaub RG, Olson KA, . . . McGinness KE (2011) Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/21389323
Yang Y, Yan FZ, Yan JS, Zhao J, Li WP, Chen XY, . . . Rao SM (2011) [Screening Drugs for Regulating Tissue Factor Gene Expression.]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19:207-210.
http://www.ncbi.nlm.nih.gov/pubmed/21362253
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 6 March 15, 2011
(The next issue will be on April 1, 2011)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PRODUCT ANNOUNCEMENT
- Purified cogulation factors - purified from human plasma, and greater than 95% pure by SDS-PAGE. http://www.haemtech.com/Products_Overview.htm
- Antibodies - Monoclonal, polyclonal and conjugated forms are available. http://www.haemtech.com/Antibodies.htm
- Custom blood collection tubes - customized to your specifications. Non-sterile, research use only. http://www.haemtech.com/Blood_Collection_Tubes.htm
DISCLAIMER: Commercial product announcements appearing in TRIGGER are provided "as is" for informational purposes only. The editors of TRIGGER have not necessarily evaluated any materials from commercial suppliers described in this newsletter or on its web sites, and we certainly are not endorsing any specific suppliers or products. Furthermore, the editors receive no revenues from any source in the course of publishing TRIGGER.
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1FGVdsJU0ltAxZc9wpEu1M6/
(No authors listed) (2010) [Diagnosis and correction of thrombohemorrhagic complications in cardiosurgical patients in the early postoperative period]. Anesteziol Reanimatol:56-59.
http://www.ncbi.nlm.nih.gov/pubmed/21400731
Agerso H, Kristensen NR, Ostergaard H, Karpf DM, Hermit MB, Pelzer H, . . . Ezban M (2011) Clearance of rFVIIa and NN1731 after intravenous administration to Beagle dogs. Eur J Pharm Sci.
http://www.ncbi.nlm.nih.gov/pubmed/21382491
Brophy DF, Martin EJ, Christian Barrett J, Nolte ME, Kuhn JG, Gerk PM, . . . Hedner U (2011) Monitoring rFVIIa 90 mug kg(-1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21362113
Brown C, Joshi B, Faraday N, Shah A, Yuh D, Rade JJ, Hogue CW (2011) Emergency Cardiac Surgery in Patients with Acute Coronary Syndromes: A Review of the Evidence and Perioperative Implications of Medical and Mechanical Therapeutics. Anesth Analg.
http://www.ncbi.nlm.nih.gov/pubmed/21385977
Christensen MC, Banner C, Lefering R, Vallejo-Torres L, Morris S (2011) Quality of Life After Severe Trauma: Results From the Global Trauma Trial With Recombinant Factor VII. J Trauma.
http://www.ncbi.nlm.nih.gov/pubmed/21378585
Delluc A, Rousseau A, Delluc C, Le Moigne E, Le Gal G, Mottier D, . . . Lacut K (2011) Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21372691
Dimou AT, Syrigos KN, Saif MW (2011) Novel Agents in the Management of Pancreatic Adenocarcinoma: Phase I Studies. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011. JOP 12:114-116.
http://www.ncbi.nlm.nih.gov/pubmed/21386633
Eisenreich A, Boltzen U, Malz R, Schultheiss HP, Rauch U (2011) Overexpression of Alternatively Spliced Tissue Factor Induces the Pro-Angiogenic Properties of Murine Cardiomyocytic HL-1 Cells. Circ J.
http://www.ncbi.nlm.nih.gov/pubmed/21389637
Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, . . . Shann KG (2011) 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91:944-982.
http://www.ncbi.nlm.nih.gov/pubmed/21353044
Gando S, Sawamura A, Hayakawa M (2011) Trauma, Shock, and Disseminated Intravascular Coagulation: Lessons from the Classical Literature. Ann Surg.
http://www.ncbi.nlm.nih.gov/pubmed/21368657
Ho KM, Leonard AD (2011) Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study. Anaesth Intensive Care 39:46-54.
http://www.ncbi.nlm.nih.gov/pubmed/21375089
Holmberg H, Kiersgaard MK, Mikkelsen LF, Tranholm M (2011) Impact of blood sampling technique on blood quality and animal welfare in haemophilic mice. Lab Anim.
http://www.ncbi.nlm.nih.gov/pubmed/21382833
Ignjatovic V, Than J, Summerhayes R, Newall F, Horton S, Cochrane A, Monagle P (2011) Hemostatic Response in Paediatric Patients Undergoing Cardiopulmonary Bypass Surgery. Pediatr Cardiol.
http://www.ncbi.nlm.nih.gov/pubmed/21360266
Jiang M, Wang Z, Yu Z, Bai X, Su J, Cao L, . . . Ruan C (2011) A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21372693
Kayem G, Kurinczuk J, Alfirevic Z, Spark P, Brocklehurst P, Knight M (2011) Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG.
http://www.ncbi.nlm.nih.gov/pubmed/21392247
Krysiak R, Zmuda W, Okopien B (2011) The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia. Fundam Clin Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/21392096
Kung CW, Lee YM, Yen MH (2011) In vivo anticoagulant effect of ethyl pyruvate in endotoxemic rats. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21396682
Lockwood CJ, Huang SJ, Krikun G, Caze R, Rahman M, Buchwalder LF, Schatz F (2011) Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia. Semin Thromb Hemost 37:158-164.
http://www.ncbi.nlm.nih.gov/pubmed/21370218
Lwaleed BA, Dusse L, Cooper AJ (2011) Tissue factor dependent pathway and the diagnosis of pre-eclampsia. Semin Thromb Hemost 37:125-130.
http://www.ncbi.nlm.nih.gov/pubmed/21370212
Machlus KR, Cardenas JC, Church FC, Wolberg AS (2011) Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/21355090
Morfini M, Bjerre J (2011) Pharmacokinetics and safety of a 270 mcg kg(-1) dose of room temperature stable recombinant activated factor VII in patients with haemophilia. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/21371194
Negrev N, Tashev R, Radev R, Anogeianaki A, Ivanova M (2011) Hormones of hypothalamic-pituitary-thyroid axis are significant regulators of synthesis and secretion of vitamin K-dependent plasma coagulation factors. J Biol Regul Homeost Agents 25:21-26.
http://www.ncbi.nlm.nih.gov/pubmed/21382270
Ott I (2011) Inhibitors of the initiation of coagulation. Br J Clin Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/21392058
Rochier A, Nixon A, Yamashita N, Abe R, Madri JA, Sumpio BE (2011) Laminar shear, but not orbital shear, has a synergistic effect with thrombin stimulation on tissue factor expression in human umbilical vein endothelial cells. J Vasc Surg.
http://www.ncbi.nlm.nih.gov/pubmed/21367569
Sakai T, Inoue S, Takei M, Ogawa G, Hamazaki Y, Ota H, Koboyashi Y (2011) Activated inflammatory cells participate in thrombus size through tissue factor and plasminogen activator inhibitor-1 in acute coronary syndrome: Immunohistochemical analysis. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21388659
Schweintzger S, Schlagenhauf A, Leschnik B, Rinner B, Bernhard H, Novak M, Muntean W (2011) Microparticles in newborn cord blood: Slight elevation after normal delivery. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21376371
Uszynski M, Uszynski W (2011) Coagulation and fibrinolysis in amniotic fluid: physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia. Semin Thromb Hemost 37:165-174.
http://www.ncbi.nlm.nih.gov/pubmed/21370219
van den Born BJ, Lowenberg EC, van der Hoeven NV, de Laat B, Meijers JC, Levi M, van Montfrans GA (2011) Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis. J Hypertens.
http://www.ncbi.nlm.nih.gov/pubmed/21372741
Waters EK, Genga RM, Schwartz MC, Nelson JA, Schaub RG, Olson KA, . . . McGinness KE (2011) Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor. Blood.
http://www.ncbi.nlm.nih.gov/pubmed/21389323
Yang Y, Yan FZ, Yan JS, Zhao J, Li WP, Chen XY, . . . Rao SM (2011) [Screening Drugs for Regulating Tissue Factor Gene Expression.]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19:207-210.
http://www.ncbi.nlm.nih.gov/pubmed/21362253
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
